H2-pharma Company Profile
What is the competitive landscape for H2-PHARMA
H2-PHARMA has three approved drugs.
Summary for H2-pharma
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for H2-pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H2-pharma | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 213985-004 | Feb 6, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| H2-pharma | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 209255-001 | Dec 18, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| H2-pharma | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 213985-002 | Oct 11, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| H2-pharma | LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 208822-001 | Sep 25, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| H2-pharma | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 213985-003 | Oct 11, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
